CEO of INmune Bio Inc. Discusses Company Accomplishments at Nasdaq?s MarketSite and Announces Presentation at World Immunotherapy Congress

La Jolla, CA., Sept. 24, 2019 (GLOBE NEWSWIRE) — ?INmune Bio, Inc. (NASDAQ: INMB), an immunology company focused on developing treatments that harness the patient?s innate immune system to fight disease, today announced that RJ Tesi, M.D., Co-Founder and CEO will be featured in an interview with multimedia financial reporter, Jason Lin discussing the company?s accomplishments. The interview can be found by clicking